Why Prior Authorization for Erivedge is Essential with Humana?

On-Demand Outsourcing BPO Services for Healthcare Providers With 24/7 Coverage!

Save up to 70% on staffing costs!

Browse Specialty Staffing Services

Why Prior Authorization for Erivedge is Essential with Humana?

112 views

A doctor in a white coat and gloves is gently examining a young girl’s arm, smiling as they interact. The setting is a bright medical office with plants and a calm environment.

If you’re a healthcare provider who’s tried to get a specialized medication like Erivedge approved through Humana, you know that the prior authorization (PA) process can feel like navigating a maze. Humana, as many of you are aware, offers a variety of insurance plans. For certain high-cost or targeted medications—like Erivedge—Humana typically requires prior authorization. This step ensures that the medication is medically necessary, aligns with the patient’s diagnosis, and fits within the clinical criteria Humana has set for coverage.

So, why does Erivedge specifically require prior authorization? This medication is specifically designed for metastatic basal cell carcinoma, where treatment goals are focused on preventing the recurrence of tumors. Because of its targeted nature and intended use for advanced cases, Humana requires a prior authorization to confirm that the patient’s condition aligns with approved clinical guidelines for Erivedge. This not only supports proper patient care but also helps manage overall treatment costs.

Insurance Company Overview

Humana Inc. is a US health insurance provider that offers various plans, including individual health coverage, employer group plans, Medicare Advantage, and prescription drug plans. The company focuses on providing affordable healthcare, focusing on preventive care, chronic disease management, and healthier lifestyles. Prior authorization (PA) is required for advanced treatments and high-cost specialty medications, ensuring medical necessity and clinical guidelines align with coverage. Healthcare providers must understand PA to facilitate specialized medication approvals.

Medication and Process Overview for Prior Authorization

Let’s walk through the process, step-by-step, as if you’re filling out the PA request for Erivedge today. You’ll see that every part matters, from selecting the right ICD-10 code to documenting the medical necessity of this advanced treatment.

Step-by-Step Process for Obtaining Prior Authorization for Erivedge

Step1: Drug Information Details:

- The prescription for Erivedge was specified at the standard 150 mg capsule dose, and this request noted the need for the brand-only version of the medication. This detail is essential because, for highly specialized drugs like Erivedge, generics may not be available or appropriate for the patient’s condition.

Step2: Correct ICD Code Entry:

- Next, the specific ICD-10 code is entered—C44.91 in this case, which refers to “basal cell carcinoma of skin, unspecified.” Using this code correctly is essential. It serves as a bridge between the patient’s diagnosis and the medical justification for using Erivedge. This linkage is often the first thing insurers check when deciding whether to proceed with the PA.

Step3: Documenting the Prescriber’s Information:

- This section requires complete details about the prescribing physician, including their name, address, contact information, and medical license details. This is a simple but necessary step that verifies the prescriber’s legitimacy, allowing the insurance provider to quickly validate that the medication is being ordered by a licensed professional.

Step4: Determining Urgency Level:

- For Erivedge, a non-urgent review was selected. Most insurers, including Humana, offer options for “urgent” and “standard” or “non-urgent” processing. Since this was flagged as non-urgent, it followed standard timelines, which typically span a few business days but can vary based on workload and plan specifics.

Step5: Medical Justification – Making Your Case Clear:

- At this stage, clear and concise comments were added to justify why Erivedge was the best choice. The explanation emphasized Erivedge’s role in reducing tumor recurrence, particularly for patients with metastatic basal cell carcinoma who had limited alternatives. Medical justifications like this, backed by the patient’s history or other relevant details, add significant weight to the PA request, making it easier for the insurance team to approve the medication.

Step6: Attaching Supporting Documents:

- Now, you might be wondering what kind of documents actually make a difference here. Supporting evidence can include medical notes, prior treatment history, and any imaging or test results that back up the diagnosis and the necessity of Erivedge for this specific case. By attaching these documents, you’re providing Humana with everything they need to make an informed decision—reducing the chance of follow-up requests or potential delays.

Step7: Final Submission of the Completed Form:

- Once every section of the form was filled out—ensuring no details were overlooked—the PA request was submitted to Humana for review. From here, it entered the official review process, during which Humana’s team of clinicians and administrators checked for alignment with their guidelines and requirements.

ICD and CPT Codes Explained

Using the right ICD and CPT codes is critical in the PA process, especially for high-cost or targeted medications. In this case, ICD-10 code C44.91 (basal cell carcinoma of skin, unspecified) directly connects the condition with the need for Erivedge. This connection is foundational for accurate claims processing, helping align the diagnosis with Humana’s criteria for Erivedge.

Frequently Asked Questions (FAQs)

1. Why is prior authorization required for Erivedge?
Given Erivedge’s role in treating advanced cases of basal cell carcinoma, Humana requires prior authorization to confirm the drug’s suitability for the patient’s condition. This process ensures that the use of Erivedge is in line with both clinical best practices and Humana’s criteria for treatment.

2. What can I do if the prior authorization is denied?
In the event of a denial, you have the option to appeal. Start by gathering additional documentation that can further support the medical necessity of Erivedge or offer alternative justifications. An appeal letter from the prescribing physician, providing a detailed rationale for the drug’s necessity, can also be effective in the appeals process.

3. How long does the prior authorization process take?
For a non-urgent request like this one, the standard processing time applies, although it can vary depending on the specifics of the patient’s insurance plan and policy. Typically, non-urgent PA requests are processed within several business days.

What Did We Learn?

Securing prior authorization for specialized medications like Erivedge doesn’t have to be overwhelming if you keep a few key principles in mind:

Every Detail Counts: From accurate ICD coding to complete physician details, every section of the PA request contributes to the overall success of the application.
Documentation is Essential: By providing thorough supporting documents, you’re making it easier for the insurance provider to understand why this medication is medically necessary for the patient.
Know Your Insurer’s Requirements: Each insurer has unique guidelines, and knowing Humana’s criteria can expedite your PA process.

Disclaimer

The information in our posts is meant to inform and educate both healthcare providers and readers seeking a better understanding of the prior authorization process. However, it is not a substitute for professional advice. Insurance requirements, policies, and approval processes can vary widely and change over time. For accurate guidance, healthcare providers should consult directly with insurers or use professional resources, while patients should reach out to their insurance providers or healthcare professionals for advice specific to their situation.

This content does not establish any patient-caregiver or client-service relationship. Staffingly, Inc. assumes no liability for actions taken based on information provided in these posts.

For tailored support and professional services,

please contact Staffingly, Inc. at (800) 489-5877

Email : support@staffingly.com